Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Coughlan

Showing results (71-80 of 158) with videos related to

Pageof 16
Sort By:
Diabetes|October 19, 2010
miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expressionBo Wang, Philip Koh, Catherine Winbanks, et al.
European Journal of Neurology|September 22, 2012
High on-treatment platelet reactivity on commonly prescribed antiplatelet agents following transient ischaemic attack or ischaemic stroke: results from the Trinity Antiplatelet Responsiveness (TRAP) studyW O Tobin, J A Kinsella, T Coughlan, et al.
International Journal of Geriatric Psychiatry|September 29, 2011
Subjective memory complaints in community dwelling healthy older people: the influence of brain and psychopathologyM Bartley, A L Bokde, M Ewers, et al.
Scientific Reports|September 22, 2019
Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretionAowen Zhuang, Felicia Y T Yap, Domenica McCarthy, et al.
Endocrinology|November 18, 2006
Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?Melinda T Coughlan, Vicki Thallas-Bonke, Josefa Pete, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|May 4, 2024
Sex differences in histopathological markers of cerebral amyloid angiopathy and related hemorrhageEmma A Koemans, Valentina Perosa, Whitney M Freeze, et al.
Frontiers in Nutrition|April 11, 2022
Reduced Growth, Altered Gut Microbiome and Metabolite Profile, and Increased Chronic Kidney Disease Risk in Young Pigs Consuming a Diet Containing Highly Resistant ProteinMargaret Murray, Melinda T Coughlan, Anne Gibbon, et al.
Diabetes|September 9, 2010
Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mousePhyllis Chew, Derek Y C Yuen, Nada Stefanovic, et al.
Diabetes|October 26, 2007
Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathwayVicki Thallas-Bonke, Suzanne R Thorpe, Melinda T Coughlan, et al.
Journal of Clinical and Translational Science|November 29, 2023
The Evolve to Next-Gen ACT Network: An evolving open-access, real-world data resource primed for real-world evidence research across the Clinical and Translational Science Award ConsortiumElaine H Morrato, Lindsay A Lennox, James W Dearing, et al.
Pageof 16

Showing results (71-80 of 158) with videos related to

Sort By:
Pageof 16
Diabetes|October 19, 2010
miR-200a Prevents renal fibrogenesis through repression of TGF-β2 expressionBo Wang, Philip Koh, Catherine Winbanks, et al.
European Journal of Neurology|September 22, 2012
High on-treatment platelet reactivity on commonly prescribed antiplatelet agents following transient ischaemic attack or ischaemic stroke: results from the Trinity Antiplatelet Responsiveness (TRAP) studyW O Tobin, J A Kinsella, T Coughlan, et al.
International Journal of Geriatric Psychiatry|September 29, 2011
Subjective memory complaints in community dwelling healthy older people: the influence of brain and psychopathologyM Bartley, A L Bokde, M Ewers, et al.
Scientific Reports|September 22, 2019
Globally elevating the AGE clearance receptor, OST48, does not protect against the development of diabetic kidney disease, despite improving insulin secretionAowen Zhuang, Felicia Y T Yap, Domenica McCarthy, et al.
Endocrinology|November 18, 2006
Combination therapy with the advanced glycation end product cross-link breaker, alagebrium, and angiotensin converting enzyme inhibitors in diabetes: synergy or redundancy?Melinda T Coughlan, Vicki Thallas-Bonke, Josefa Pete, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|May 4, 2024
Sex differences in histopathological markers of cerebral amyloid angiopathy and related hemorrhageEmma A Koemans, Valentina Perosa, Whitney M Freeze, et al.
Frontiers in Nutrition|April 11, 2022
Reduced Growth, Altered Gut Microbiome and Metabolite Profile, and Increased Chronic Kidney Disease Risk in Young Pigs Consuming a Diet Containing Highly Resistant ProteinMargaret Murray, Melinda T Coughlan, Anne Gibbon, et al.
Diabetes|September 9, 2010
Antiatherosclerotic and renoprotective effects of ebselen in the diabetic apolipoprotein E/GPx1-double knockout mousePhyllis Chew, Derek Y C Yuen, Nada Stefanovic, et al.
Diabetes|October 26, 2007
Inhibition of NADPH oxidase prevents advanced glycation end product-mediated damage in diabetic nephropathy through a protein kinase C-alpha-dependent pathwayVicki Thallas-Bonke, Suzanne R Thorpe, Melinda T Coughlan, et al.
Journal of Clinical and Translational Science|November 29, 2023
The Evolve to Next-Gen ACT Network: An evolving open-access, real-world data resource primed for real-world evidence research across the Clinical and Translational Science Award ConsortiumElaine H Morrato, Lindsay A Lennox, James W Dearing, et al.
Pageof 16